.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2014 for a who...
.On the heels of a stage 3 succeed that stopped working to excite financiers, Ironwood Pharmaceutica...
.Don't quit Monte Rosa Rehabs right now. The Boston-based biotech is having a ball after authorizing...
.Invite to today's Chutes & Ladders, our summary of notable leadership hirings, shootings and ret...
.Commemorating his company's upsized initial public offering (IPO), Septerna chief executive officer...
.AbbVie has come back to the source of its antipsychotic giant Vraylar in search of yet another smas...
.GenSight Biologics is full weeks out of losing amount of money. Again. The biotech simply has enoug...
.Monopar Rehabs is recuperating a medicine coming from the scrap heap of AstraZeneca's uncommon cond...
.Along with new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of profess...
.After developing a gene treatment alliance with Dyno Therapeutics in 2020, Roche is back for even m...